Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

December 24, 2021

Study Completion Date

December 24, 2021

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Web Simulation Tool (WST)

WST will allow users of the Control-IQ system replay treatment scenarios in computer simulation, thereby allowing user training with carbohydrate and insulin action.

DEVICE

Behavioral Adaptation Module (BAM)

BAM provides on-demand information to the participant primarily on glycemic risks.

DEVICE

Auto Titration Module (ATM)

ATM provides recommendations to the participant to periodically update insulin parameters.

DEVICE

Automated Insulin Delivery (AID) System

The t:slim X2 insulin pump with Control-IQ technology, Tandem Diabetes Care will be the AID in this study.

Trial Locations (1)

22903

University of Virginia Center for Diabetes Technology, Charlottesville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Virginia

OTHER

NCT04784637 - Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery | Biotech Hunter | Biotech Hunter